Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Chemother Pharmacol. 2007 Feb;59(2):235-49. Epub 2006 Sep 14.

Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity.

Author information

1
Department of OB/GYN, GSM, UTMCK, University of Tennessee, Alcoa Highway, Knoxville, TN 37920, USA.

Abstract

PURPOSE:

Paclitaxel (PTX) is a widely used chemotherapy agent and may cause cell death by apoptosis subsequent to microtubule (MT) disruption. In this paper, we have investigated whether cell cycle transit and or Cdc2 (Cdk1) activity is required for the apoptosis induced by PTX.

METHODS:

Cell cycle was analyzed by flow cytometry, Cdc2 was assayed bio chemically. Cdc2 activity was decreased by siRNA and dominant negative (dn) Cdc2 expression. Cells were arrested by chemical or biological inhibitors in a G1 or S phase. Apoptosis was measured by DNA fragmentation and examination of nuclei by microscopy. JNK and AKT activations were assessed as well.

RESULTS:

Cell cycle inhibition was highly effective in decreasing PTX induced apoptosis. MT morphology was not altered by these inhibitors. PTX induced JNK activity or AKT mediated BAD phosphorylation was unaffected by cell cycle inhibitors. Abrogation of Cdc 2 activity was without effect on PTX induced apoptosis.

CONCLUSIONS:

While cell cycle transit is required for PTX induced apoptosis; Cdc2 activity is not required.

PMID:
16972069
DOI:
10.1007/s00280-006-0262-1
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center